摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-methoxy-1-[4-[2-[1-(6-methylpyridazin-3-yl)-4-piperidyl]ethoxy]phenyl]ethanimine

中文名称
——
中文别名
——
英文名称
N-methoxy-1-[4-[2-[1-(6-methylpyridazin-3-yl)-4-piperidyl]ethoxy]phenyl]ethanimine
英文别名
(E)-N-methoxy-1-[4-[2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy]phenyl]ethanimine
N-methoxy-1-[4-[2-[1-(6-methylpyridazin-3-yl)-4-piperidyl]ethoxy]phenyl]ethanimine化学式
CAS
——
化学式
C21H28N4O2
mdl
——
分子量
368.479
InChiKey
DDFRDFIDPYAMQZ-JJIBRWJFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    27
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    59.8
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为产物:
    参考文献:
    名称:
    An Orally Bioavailable Oxime Ether Capsid Binder with Potent Activity against Human Rhinovirus
    摘要:
    A series of capsid-binding compounds was screened against human rhinovirus (HRV) using a CPE based assay. The ethyl oxime ether 14 was found to have outstanding anti-HRV activity (median IC50 4.75 ng/mL), and unlike the equivalent ethyl ester compound 3 (Pirodavir), it has good oral bioavailability, making it a promising development candidate. Compound 14 illustrates that an oxime ether group can act as a metabolically stable bioisostere for an ester functionality.
    DOI:
    10.1021/jm0202876
点击查看最新优质反应信息

文献信息

  • An Orally Bioavailable Oxime Ether Capsid Binder with Potent Activity against Human Rhinovirus
    作者:Keith G. Watson、Renee N. Brown、Rachel Cameron、David K. Chalmers、Stephanie Hamilton、Betty Jin、Guy Y. Krippner、Angela Luttick、Darryl B. McConnell、Phillip A. Reece、Jane Ryan、Pauline C. Stanislawski、Simon P. Tucker、Wen-Yang Wu、Dale L. Barnard、Robert W. Sidwell
    DOI:10.1021/jm0202876
    日期:2003.7.1
    A series of capsid-binding compounds was screened against human rhinovirus (HRV) using a CPE based assay. The ethyl oxime ether 14 was found to have outstanding anti-HRV activity (median IC50 4.75 ng/mL), and unlike the equivalent ethyl ester compound 3 (Pirodavir), it has good oral bioavailability, making it a promising development candidate. Compound 14 illustrates that an oxime ether group can act as a metabolically stable bioisostere for an ester functionality.
查看更多